Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2005
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572725A1 Novel chi-conotoxin peptides (-i)
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572704A1 Phosphorus-containing piperazine derivatives as ccr1 antagonists
09/14/2005EP1572672A1 Benzoxazocines and their use as monoamine-reuptake inhibitors
09/14/2005EP1572671A1 Non-steroidal anti-inflammatory agents
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572653A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
09/14/2005EP1572632A1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists
09/14/2005EP1572627A1 Drugs for chronic pain
09/14/2005EP1572246A2 Novel compositions of magnetic particles covered with gem-bisphosphonate derivatives
09/14/2005EP1572241A1 Oral pharmaceutical compositions comprising cyclosporin
09/14/2005EP1572237A1 Combinations of vanilloid antagonist and nsaid for the treatment of pain
09/14/2005EP1572209A1 Novel quinoxalinone derivatives as bradykinin b1 antagonists
09/14/2005EP1572189A1 Method of lowering crp and reducing systemic inflammation
09/14/2005EP1572188A1 Pregabalin derivatives for the treatment of fibromyalgia and other disorders
09/14/2005EP1572187A1 Pregabalin and derivatives thereof for the treatment of fibromyalgia and other related disorders
09/14/2005EP1572183A1 Alpha-2-delta ligand for the treatment of sexual dysfunction
09/14/2005EP1572179A1 Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox1/2 inhibitor
09/14/2005EP1572178A2 Treatment of mastalgia with 4-hydroxy tamoxifen
09/14/2005EP1572172A1 Alpha2delta ligands for different pharmaceutical uses
09/14/2005EP1572093A2 Improved treatment of cancer with glutamine
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572075A2 Method for treating diseases associated with abnormal kinase activity
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1572066A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
09/14/2005EP1529048A4 Methods for the synthesis of substituted purines
09/14/2005EP1515698A4 Liposomes containing biologically active compounds
09/14/2005EP1390062A4 Modulators of elastase inhibitor secretion
09/14/2005EP1363651B1 Herbal compositions useful as chemopreventive and therapeutic agents
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1274446B1 Polysaccharidic esters of n-derivatives of glutamic acid
09/14/2005EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments
09/14/2005EP1218366B1 Method for producing cox-2 inhibitors
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005EP0970081B1 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-yl)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668758A Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
09/14/2005CN1668755A Galactosyl isomalt, method for production and use thereof
09/14/2005CN1668728A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
09/14/2005CN1668644A Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668622A 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668609A Substituted 4-aryl-4H-pyrrolo[2, 3-H]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/14/2005CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668326A Intratumorally administered lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668325A Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668286A Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhea
09/14/2005CN1668213A Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666982A Mixtures and compounds from Antrodia camphorate myceliums and use thereof
09/14/2005CN1666756A Pain-relieving navel-applied paste
09/14/2005CN1666744A Dry cow mamma perfusion agent for preventing and curing cow mastitis and preparation method thereof
09/14/2005CN1666737A Application of citric acid solution in preparation of antiphlogistic drug
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218738C Proprietary Chinese internal medicine for promoting blood circulation to stop pain
09/14/2005CN1218735C Medicine composition for treating pain in waist and lower limbs and hyperosteogeny
09/14/2005CN1218732C Preparation process of Qingkailing injection and injection powder
09/14/2005CN1218726C Heat-clearing and stagnation-dissipating particle medicine and preparation method thereof
09/14/2005CN1218724C Tincture for treating traumatic injury
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
09/13/2005US6943195 Cycloalkenone derivative
09/13/2005US6943190 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943174 6,5-Fused bicyclic heterocycles
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943167 Helix mimetics and composition and methods related thereto
09/13/2005US6943158 for treating a fibroblast growth factor receptors (FGFR) kinase mediated disorder such as atherosclerosis
09/13/2005US6943151 Method of inhibiting bone resorption and/or promoting bone formation using GLP-2 and related compounds
09/13/2005US6943148 Methods for delivering therapeutics across blood-barrier and for altering receptor binding affinity
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942983 An isolated monoclonal antibody is used for binding and detecting a polypeptide having amino acid sequence with valine at residue 835, modulate kinase activity in cells, protein kinase C
09/13/2005US6942966 Methods for processing chemical compounds having reactive functional groups
09/13/2005US6942876 Mixture of n-methyl-d-aspartate and nonsteroid antiinflammatory drug
09/13/2005US6942853 Latent fusion protein
09/13/2005US6942852 N-terminal modifications of RANTES and methods of use
09/13/2005CA2371587C Piperidine derivatives useful as ccr5 antagonists
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2323863C Methods and compositions for treating and preventing mucositis
09/13/2005CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
1 ... 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 ... 1272